The drug significantly reduced the worsening of renal function or risk of death in patients with chronic kidney disease with and without type II diabetesOriginal Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.